Delayed diagnosis and associated factors among new pulmonary tuberculosis patients diagnosed at the emergency department of a tertiary care hospital in Porto Alegre, South Brazil: a prospective patient recruitment study

BMC Infectious Diseases

Paulo de Tarso Roth Dalcin¹  Alice Mânica Muller¹  Ana Cláudia Coelho¹  Denise Rossato Silva¹  Gracieli Nadalon Deponti¹ 

[1] Universidade Federal do Rio Grande do Sul (UFRGS), Programa de Pós-Graduação em Ciências Pneumológicas da UFRGS, Serviço de Pneumologia, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil

关键词: Diagnosis;    Health care system delay;    Patient delay;    Risk factors;    Tuberculosis;   

Others  :  1145391
DOI  :  10.1186/1471-2334-13-538

 received in 2013-04-30, accepted in 2013-11-05,  发布年份 2013

【 摘 要 】

Background

Control of tuberculosis (TB) depends on early diagnosis and treatment at the primary health care level. However, many patients are still diagnosed late with TB at hospitals. The present study aimed to investigate the delay in diagnosis of TB patients at the emergency department.

Methods

This was a prospective study in a general, tertiary care, university-affiliated hospital of a city with a high prevalence of TB in Brazil. New TB patients ≥ 14 years diagnosed with pulmonary TB at the emergency department of Hospital de Clínicas de Porto Alegre were prospectively recruited between February 2010 and January 2012. The consenting patients meeting our inclusion criteria were interviewed using a pre-tested questionnaire. We evaluated the delay in time until diagnosis and identified factors associated with delayed diagnosis (patient and health care system delays).

Results

We included 153 patients. The median total time of delay, patient delay, and health care system delay were 60 (interquartile range [IQR]: 30–90.5 days), 30 (lQR: 7–60 days), and 18 (IQR: 9–39.5 days) days, respectively. The factors that were independently associated with patient delay (time ≥ 30 days) were crack (odds ratio [OR] = 4.88, p = 0.043) and cocaine (OR = 6.68, p = 0.011) use. The factors that were independently associated with health care system delay (time ≥ 18 days) were weight loss (OR = 2.76, p = 0.025), miliary pattern (OR = 5.33, p = 0.032), and fibrotic changes (OR = 0.12, p = 0.013) on chest X-ray.

Conclusions

Patient delay appears to be the main problem in this city with a high prevalence of TB in Brazil. The main factor associated with patient delay is drug abuse (crack and cocaine). Our study shows substance abuse programs need to be aware of control of TB, with health interventions focusing on TB education programs.

【 授权许可】

   
2013 Deponti et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]World Health Organization: Global Tuberculosis Report 2012. 2012. Available at: http://www.who.int webcite
• [2]Prefeitura Municipal de Porto Alegre: Boletim Epidemiológico. 2012. Avalilable at: http://www.portoalegre.rs.gov.br webcite
• [3]Tuberculosis Coalition for Technical Assistance: International Standards for Tuberculosis Care (ISTC). 2006. Available at: http://www.who.int webcite
• [4]Lambert ML, Van der Stuyft P: Delays to tuberculosis treatment: shall we continue to blame the victim? Trop Med Int Health 2005, 10:945-946.
• [5]Sreeramareddy CT, Panduru KV, Menten J, Van den Ende J: Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature. BMC Infect Dis 2009, 9:91. BioMed Central Full Text
• [6]Storla DG, Yimer S, Bjune GA: A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 2008, 8:15. BioMed Central Full Text
• [7]Watkins RE, Plant AJ: Pathways to treatment for tuberculosis in Bali: patient perspectives. Qual Health Res 2004, 14:691-703.
• [8]Machado AC, Steffen RE, Oxlade O, Menzies D, Kritski A, Trajman A: Factors associated with delayed diagnosis of pulmonary tuberculosis in the state of Rio de Janeiro, Brazil. J Bras Pneumol 2011, 37:512-520.
• [9]Maior ML, Guerra RL, Cailleaux-Cezar M, Golub JE, Conde MB: Time from symptom onset to the initiation of treatment of pulmonary tuberculosis in a city with a high incidence of the disease. J Bras Pneumol 2012, 38:202-209.
• [10]dos Santos MA, Albuquerque MF, Ximenes RA, Lucena-Silva NL, Braga C, Campelo AR, et al.: Risk factors for treatment delay in pulmonary tuberculosis in Recife, Brazil. BMC Public Health 2005, 5:25. BioMed Central Full Text
• [11]Lorent N, Mugwaneza P, Mugabekazi J, Gasana M, Van BS, Clerinx J, et al.: Risk factors for delay in the diagnosis and treatment of tuberculosis at a referral hospital in Rwanda. Int J Tuberc Lung Dis 2008, 12:392-396.
• [12]Ministério da Saúde: Indicadores de morbidade e fatores de risco. Brasil: Taxa de incidência de AIDS; 2006. Ref Type: Generic
• [13]Conde MB, Melo FA, Marques AM, Cardoso NC, Pinheiro VG, Dalcin PT, et al.: III Brazilian thoracic association guidelines on tuberculosis. J Bras Pneumol 2009, 35:1018-1048.
• [14]Ward J, Siskind V, Konstantinos A: Patient and health care system delays in Queensland tuberculosis patients, 1985–1998. Int J Tuberc Lung Dis 2001, 5:1021-1027.
• [15]Rossato SD, Muller AM, Dalcin PT: Factors associated with delayed diagnosis of tuberculosis in hospitalized patients in a high TB and HIV burden setting: a cross-sectional study. BMC Infect Dis 2012, 12:57. BioMed Central Full Text
• [16]Oeltmann JE, Kammerer JS, Pevzner ES, Moonan PK: Tuberculosis and substance abuse in the United States, 1997–2006. Arch Intern Med 2009, 169:189-197.
• [17]Shamaei M, Marjani M, Baghaei P, Chitsaz E, Rezaei TE, Abrishami Z, et al.: Drug abuse profile - patient delay, diagnosis delay and drug resistance pattern - among addict patients with tuberculosis. Int J STD AIDS 2009, 20:320-323.
• [18]Sherman LF, Fujiwara PI, Cook SV, Bazerman LB, Frieden TR: Patient and health care system delays in the diagnosis and treatment of tuberculosis. Int J Tuberc Lung Dis 1999, 3:1088-1095.
• [19]Zerbini E, Chirico MC, Salvadores B, Amigot B, Estrada S, Algorry G: Delay in tuberculosis diagnosis and treatment in four provinces of Argentina. Int J Tuberc Lung Dis 2008, 12:63-68.
• [20]Prefeitura Municipal de Porto Alegre: Boletim Epidemiológico. Porto Alegre, Brasil; 2008. Available at: http://www.portoalegre.rs.gov.br webcite
• [21]Lacroix C, Martin P, Turcotte S, DeRoche S, Magluilo V, Lacroix C: The delay in diagnosis of tuberculosis in the Monteregie region of Quebec, Canada. Mcgill J Med 2008, 11:124-131.
• [22]Schneider D, McNabb SJ, Safaryan M, Davidyants V, Niazyan L, Orbelyan S: Reasons for delay in seeking care for tuberculosis, republic of armenia, 2006–2007. Interdiscip Perspect Infect Dis 2010, 2010:412624.
• [23]Solari L, Acuna-Villaorduna C, Soto A, Agapito J, Perez F, Samalvides F, et al.: A clinical prediction rule for pulmonary tuberculosis in emergency departments. Int J Tuberc Lung Dis 2008, 12:619-624.
• [24]Lin CY, Lin WR, Chen TC, Lu PL, Huang PM, Tsai ZR, et al.: Why is in-hospital diagnosis of pulmonary tuberculosis delayed in southern Taiwan? J Formos Med Assoc 2010, 109:269-277.
• [25]Ministério da Saúde: Programa Nacional de Controle da Tuberculose. 2011. Available at: http://www.saude.gov.br webcite
• [26]Kramer F, Modilevsky T, Waliany AR, Leedom JM, Barnes PF: Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am J Med 1990, 89:451-456.
• [27]Needham DM, Foster SD, Tomlinson G, Godfrey-Faussett P: Socio-economic, gender and health services factors affecting diagnostic delay for tuberculosis patients in urban Zambia. Trop Med Int Health 2001, 6:256-259.
• [28]Franco J, Blanquer R, Flores J, Fernandez E, Plaza P, Nogueira JM: Analysis of the diagnostic delay in tuberculosis. Med Clin (Barc) 1996, 107:453-457.
• [29]Lawn SD, Afful B, Acheampong JW: Pulmonary tuberculosis: diagnostic delay in Ghanaian adults. Int J Tuberc Lung Dis 1998, 2:635-640.
• [30]Ngamvithayapong J, Yanai H, Winkvist A, Diwan V: Health seeking behaviour and diagnosis for pulmonary tuberculosis in an HIV-epidemic mountainous area of Thailand. Int J Tuberc Lung Dis 2001, 5:1013-1020.
• [31]Oeltmann JE, Oren E, Haddad MB, Lake L, Harrington TA, Ijaz K, et al.: Tuberculosis outbreak in marijuana users, Seattle, Washington, 2004. Emerg Infect Dis 2006, 12:1156-1159.
• [32]Chin DP, Crane CM, Diul MY, Sun SJ, Agraz R, Taylor S, et al.: Spread of Mycobacterium tuberculosis in a community implementing recommended elements of tuberculosis control. JAMA 2000, 283:2968-2974.
• [33]Malakmadze N, Gonzalez IM, Oemig T, Isiadinso I, Rembert D, McCauley MM, et al.: Unsuspected recent transmission of tuberculosis among high-risk groups: implications of universal tuberculosis genotyping in its detection. Clin Infect Dis 2005, 40:366-373.
• [34]Malotte CK, Rhodes F, Mais KE: Tuberculosis screening and compliance with return for skin test reading among active drug users. Am J Public Health 1998, 88:792-796.
• [35]Perlman DC, Gourevitch MN, Trinh C, Salomon N, Horn L, Des Jarlais DC: Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program. J Urban Health 2001, 78:550-567.
• [36]Riley ED, Vlahov D, Huettner S, Beilenson P, Bonds M, Chaisson RE: Characteristics of injection drug users who utilize tuberculosis services at sites of the Baltimore city needle exchange program. J Urban Health 2002, 79:113-127.